Items where Division is "Current Faculties > Faculty of Medicine > Southampton NIHR CRUK Experimental Cancer Medicine Centre" and Year is 2021
 | Up a level |
Number of items: 10.
Nervous and muscular adverse events after covid‐19 vaccination: A systematic review and meta‐analysis of clinical trials - Jiaxin Chen, Yuangui Cai, Yicong Chen, Anthony P. Williams, Yifang Gao and Jinsheng Zeng
Type: Review
| 2021
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy - Simon Eschweiler, James Clarke, Ciro Ramírez-suástegui, Bharat Panwar, Ariel Madrigal, Serena J. Chee, Ioannis Karydis, Edwin Woo, Aiman Alzetani, Somaia Elsheikh, C. J. Hanley, G. J. Thomas, Peter S. Friedmann, Tilman Sanchez-elsner, Ferhat Ay, Christian H. Ottensmeier and Pandurangan Vijayanand
Type: Article
| 2021
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial - Christopher P. Fox, Ayesha S. Ali, Graham McIlroy, Steffi Thust, Nicolás Martinez-Calle, Aimee E. Jackson, Louise M. Hopkins, Catherine M. Thomas, Shireen Kassam, Josh Wright, Sridhar Chaganti, Jeffery Smith, Ian Chau, Dominic Culligan, Kim M. Linton, Graham P. Collins, Andrés J. M. Ferreri, David Lewis, Andrew J. Davies, Rod Johnson, Dorothee P. Auer and Kate Cwynarski
Type: Article
| 2021
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study - Mehdi Hamadani, Graham P Collins, Paolo F Caimi, Felipe Samaniego, Alexander Spira, Andrew Davies, John Radford, Tobias Menne, Anand Karnad, Jasmine M Zain, Paul Fields, Karin Havenith, Hans G Cruz, Shui He, Joseph Boni, Jay Feingold, Jens Wuerthner and Steven Horwitz
Type: Article
| 2021
Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives - Christopher J. Hanley and Gareth J. Thomas
Type: Article
| 2021
| Item not available on this server.
CD8 T-cell-mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer - Marc Hardwick, Luke Nolan, James Nicoll, Sanjay Jogai, Edurne Arriola, Debora Joseph-Pietras, Jeanette Norman, Christian Ottensmeier and Ian Galea
Type: Article
| 2021
Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma - Sean H. Lim, Nicola Campbell, Marina Johnson, Debora Joseph-Pietras, Graham P. Collins, Ann O'Callaghan, Christopher Fox, Matthew Ahearne, Peter W.M. Johnson, David Goldblatt and Andrew J. Davies
Type: Article
| 2021
| Item not available on this server.
The hydropathy index of the HCDR3 region of the B-Cell receptor identifies two subgroups of IGHV-mutated chronic lymphocytic leukemia patients with distinct outcome - Arancha Rodríguez-Caballero, Blanca Fuentes Herrero, Guillermo Oliva Ariza, Ignacio Criado, Miguel Alcoceba, Carlos Prieto, María Pérez Caro, Andrés C García-Montero, Marcos González Díaz, Francesco Forconi, Ana Bela Sarmento-Ribeiro, Julia Almeida and Alberto Orfao
Type: Article
| 2021
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial - Bernadett Szabados, Alejo Rodriguez-Vida, Ignacio Durán, Simon J Crabb, Michiel S Van Der Heijden, Albert Font Pous, Gwenaelle Gravis, Urbano Anido Herranz, Andrew Protheroe, Alain Ravaud, Denis Maillet, Maria J Mendez-Vidal, Cristina Suárez, Mark Linch, Aaron Prendergast, Charlotte Tyson, Kelly Mousa, Daniel Castellano and Thomas Powles
Type: Article
| 2021
| Item not available on this server.
Analysis of immune landscape in pancreatic and ileal neuroendocrine tumours demonstrates an immune cold tumour microenvironment - Lulu Tanno, Salma Naheed, Jonathan Dunbar, Jo Tod, Maria A Lopez, Julian Taylor, Maria Machado, Bryan Green, Margaret Ashton-Key, Serena J Chee, Oliver Wood, Neil W Pearce, Gareth J Thomas, Peter S Friedmann, Judith Cave and Christian H Ottensmeier
Type: Article
| 2021
| Item not available on this server.